Iowa Association of Pathologists Annual Meeting

Join the Iowa Association of Pathologists at their Annual Meeting on November 11th at Glen Oaks Country Club in Des Moines for this FREE event!

Agenda: 

5:30 - 6:30 pm Cocktail hour with Exhibitors

6:30 - 6:40 pm Welcome and Introduction | Dr. Bryan Steussy, IAP President

6:40 - 7:15 pm “The CAP: Your Professional and Advocacy Home” | Dr. Jared Abbott, CAP Representative

7:15 - 8:15 pm  “Interesting Cutaneous Soft Tissue Tumors from UNMC” | Dr. Scott Lauer, Director of Pathology Residency Training Program at the University of Nebraska Medical Center

8:15 pm  Adjourn

Thanks to the support our exhibitors, this event is now FREE TO ATTEND!

Please email mlyon@iowamedical.org if you have any questions. 

CME Information: 

ACCREDITATION STATEMENTS

• MD:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the IMS. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity. 

• DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
• Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.

EDUCATIONAL GRANTS: No ineligible company provided financial support for this continuing education activity. 

DISCLOSURES: The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

• Scott R. Lauer, MD, Speaker
• Mary Lyon, Activity Director and Planning Committee Member
• Bryan Steussy, MD, Planning Committee Member

DISCLAIMER: The information provided at this activity is for continuing education. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.